Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| BINDLEY WILLIAM E | Director, 10% Owner, Other | 14 | $0 | $189.85M | 2026-09-27 |
| Mudd William Franklin | See Remarks | 4 | $0 | $0 | 2026-09-27 |
| Martin David Norman | See Remarks | 4 | $0 | $0 | 2026-09-27 |
| Crisafulli Chris | See Remarks | 4 | $0 | $0 | 2026-09-27 |
| Towns Douglas | See Remarks | 4 | $0 | $0 | 2026-09-27 |
| Tuch Jeffrey | See Remarks | 4 | $0 | $0 | 2026-09-27 |
| Eakins Richard | Senior Vice President, Sales | 4 | $0 | $0 | 2026-09-27 |
| Weir Robert | See Remarks | 4 | $0 | $0 | 2026-09-27 |
| Bindley Capital Partners I, LLC | 10% Owner, Other | 11 | $0 | $189.85M | 2026-09-27 |
| Pharmacy Investors, LLC | Other | 11 | $0 | $44.00M | 2026-09-27 |
| Forbes Kendall | See Remarks | 18 | $0 | $18.66M | 2026-09-27 |
| Morris David K | See Remarks, Director, Other | 17 | $0 | $14.40M | 2026-09-27 |
| Burke Fred | See Remarks, Director, Other | 16 | $0 | $37.79M | 2026-09-27 |
| Salentine Thomas J Jr | Director, 10% Owner, Other | 15 | $500.0K | $189.85M | 2026-09-27 |
| Ackerman John | Director, Other | 28 | $0 | $58.67M | 2026-09-27 |
| Cardinal Equity Fund, L.P. | Other | 11 | $0 | $14.66M | 2026-09-27 |
| Patchett Mary Sue | Director | 4 | $50.0K | $0 | 2026-05-05 |
| COSLER STEVEN D | Director | 6 | $348.3K | $0 | 2026-05-05 |
| LEWIS RANDALL J | Director | 4 | $50.0K | $0 | 2026-05-05 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Towns Douglas | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 23,450 | — | $0 | 0 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner | M Exercise deriv | 2026-09-27 | 2026-09-28 | 6,100,175 | — | $0 | 0 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 471,057 | — | $0 | 0 | SEC↗ |
| Eakins Richard | Senior Vice President, Sales | M Exercise deriv | 2026-09-27 | 2026-09-28 | 36,052 | — | $0 | 0 | SEC↗ |
| Crisafulli Chris | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 18,931 | — | $0 | 0 | SEC↗ |
| Morris David K | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 641,870 | — | $0 | 0 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | M Exercise deriv | 2026-09-27 | 2026-09-28 | 6,100,175 | — | $0 | 0 | SEC↗ |
| Forbes Kendall | Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 608,570 | — | $0 | 0 | SEC↗ |
| Tuch Jeffrey | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 55,578 | — | $0 | 0 | SEC↗ |
| Burke Fred | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 1,298,825 | — | $0 | 0 | SEC↗ |
| Pharmacy Investors, LLC | Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 1,413,939 | — | $0 | 0 | SEC↗ |
| Martin David Norman | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 39,865 | — | $0 | 0 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner | M Exercise deriv | 2026-09-27 | 2026-09-28 | 6,100,175 | — | $0 | 0 | SEC↗ |
| Ackerman John | Director | M Exercise deriv | 2026-09-27 | 2026-09-28 | 1,413,939 | — | $0 | 0 | SEC↗ |
| Ackerman John | Director | M Exercise deriv | 2026-09-27 | 2026-09-28 | 471,057 | — | $0 | 0 | SEC↗ |
| Weir Robert | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 23,450 | — | $0 | 0 | SEC↗ |
| Mudd William Franklin | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 38,282 | — | $0 | 0 | SEC↗ |
| Towns Douglas | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 23,450 | — | $0 | 113,006 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner | M Exercise | 2026-09-27 | 2026-09-28 | 6,100,175 | — | $0 | 16,669,666 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | M Exercise | 2026-09-27 | 2026-09-28 | 471,057 | — | $0 | 1,287,237 | SEC↗ |
| Eakins Richard | Senior Vice President, Sales | M Exercise | 2026-09-27 | 2026-09-28 | 36,052 | — | $0 | 134,930 | SEC↗ |
| Crisafulli Chris | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 18,931 | — | $0 | 53,057 | SEC↗ |
| Morris David K | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 641,870 | — | $0 | 896,341 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | M Exercise | 2026-09-27 | 2026-09-28 | 6,100,175 | — | $0 | 16,669,666 | SEC↗ |
| Forbes Kendall | Other | M Exercise | 2026-09-27 | 2026-09-28 | 608,570 | — | $0 | 1,651,059 | SEC↗ |
| Tuch Jeffrey | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 55,578 | — | $0 | 231,847 | SEC↗ |
| Burke Fred | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 1,298,825 | — | $0 | 3,438,064 | SEC↗ |
| Pharmacy Investors, LLC | Other | M Exercise | 2026-09-27 | 2026-09-28 | 1,413,939 | — | $0 | 3,863,806 | SEC↗ |
| Martin David Norman | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 39,865 | — | $0 | 140,905 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner | M Exercise | 2026-09-27 | 2026-09-28 | 6,100,175 | — | $0 | 16,669,666 | SEC↗ |
| Ackerman John | Director | M Exercise | 2026-09-27 | 2026-09-28 | 1,413,939 | — | $0 | 3,863,806 | SEC↗ |
| Ackerman John | Director | M Exercise | 2026-09-27 | 2026-09-28 | 471,057 | — | $0 | 1,287,237 | SEC↗ |
| Weir Robert | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 23,450 | — | $0 | 103,333 | SEC↗ |
| Mudd William Franklin | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 38,282 | — | $0 | 136,747 | SEC↗ |
| Mudd William Franklin | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 38,282 | — | — | 0 | SEC↗ |
| Mudd William Franklin | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 38,282 | — | — | 136,747 | SEC↗ |
| Weir Robert | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 23,450 | — | — | 0 | SEC↗ |
| Weir Robert | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 23,450 | — | — | 103,333 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner, Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 6,100,175 | — | — | 0 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner, Other | M Exercise | 2026-09-27 | 2026-09-28 | 6,100,175 | — | — | 16,669,666 | SEC↗ |
| Martin David Norman | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 39,865 | — | — | 0 | SEC↗ |
| Martin David Norman | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 39,865 | — | — | 140,905 | SEC↗ |
| Pharmacy Investors, LLC | Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 1,413,939 | — | — | 0 | SEC↗ |
| Pharmacy Investors, LLC | Other | M Exercise | 2026-09-27 | 2026-09-28 | 1,413,939 | — | — | 3,863,806 | SEC↗ |
| Tuch Jeffrey | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 55,578 | — | — | 0 | SEC↗ |
| Tuch Jeffrey | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 55,578 | — | — | 231,847 | SEC↗ |
| Morris David K | See Remarks, Director, Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 641,870 | — | — | 0 | SEC↗ |
| Morris David K | See Remarks, Director, Other | M Exercise | 2026-09-27 | 2026-09-28 | 641,870 | — | — | 896,341 | SEC↗ |
| Towns Douglas | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 23,450 | — | — | 0 | SEC↗ |
| Towns Douglas | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 23,450 | — | — | 113,006 | SEC↗ |
| Forbes Kendall | Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 608,570 | — | — | 0 | SEC↗ |
| Forbes Kendall | Other | M Exercise | 2026-09-27 | 2026-09-28 | 608,570 | — | — | 1,651,059 | SEC↗ |
| Eakins Richard | Senior Vice President, Sales | M Exercise deriv | 2026-09-27 | 2026-09-28 | 36,052 | — | — | 0 | SEC↗ |
| Eakins Richard | Senior Vice President, Sales | M Exercise | 2026-09-27 | 2026-09-28 | 36,052 | — | — | 134,930 | SEC↗ |
| Crisafulli Chris | See Remarks | M Exercise deriv | 2026-09-27 | 2026-09-28 | 18,931 | — | — | 0 | SEC↗ |
| Crisafulli Chris | See Remarks | M Exercise | 2026-09-27 | 2026-09-28 | 18,931 | — | — | 53,057 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 471,057 | — | — | 0 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | M Exercise | 2026-09-27 | 2026-09-28 | 471,057 | — | — | 1,287,237 | SEC↗ |
| Burke Fred | See Remarks, Director, Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 1,298,825 | — | — | 0 | SEC↗ |
| Burke Fred | See Remarks, Director, Other | M Exercise | 2026-09-27 | 2026-09-28 | 1,298,825 | — | — | 3,438,064 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner, Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 6,100,175 | — | — | 0 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner, Other | M Exercise | 2026-09-27 | 2026-09-28 | 6,100,175 | — | — | 16,669,666 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner, Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 6,100,175 | — | — | 0 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner, Other | M Exercise | 2026-09-27 | 2026-09-28 | 6,100,175 | — | — | 16,669,666 | SEC↗ |
| Ackerman John | Director, Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 471,057 | — | — | 0 | SEC↗ |
| Ackerman John | Director, Other | M Exercise deriv | 2026-09-27 | 2026-09-28 | 1,413,939 | — | — | 0 | SEC↗ |
| Ackerman John | Director, Other | M Exercise | 2026-09-27 | 2026-09-28 | 471,057 | — | — | 1,287,237 | SEC↗ |
| Ackerman John | Director, Other | M Exercise | 2026-09-27 | 2026-09-28 | 1,413,939 | — | — | 3,863,806 | SEC↗ |
| LEWIS RANDALL J | Director | A Award | 2026-05-05 | 2026-05-07 | 4,028 | — | $0 | 15,071 | SEC↗ |
| COSLER STEVEN D | Director | A Award | 2026-05-05 | 2026-05-07 | 4,028 | — | $0 | 29,012 | SEC↗ |
| Patchett Mary Sue | Director | A Award | 2026-05-05 | 2026-05-07 | 4,028 | — | $0 | 15,071 | SEC↗ |
| Burke Fred | See Remarks | M Exercise deriv | 2026-03-28 | 2026-03-31 | 1,298,826 | — | $0 | 1,298,825 | SEC↗ |
| Ackerman John | Director | M Exercise deriv | 2026-03-28 | 2026-03-31 | 471,057 | — | $0 | 471,057 | SEC↗ |
| Ackerman John | Director | M Exercise deriv | 2026-03-28 | 2026-03-31 | 1,413,939 | — | $0 | 1,413,939 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner | M Exercise deriv | 2026-03-28 | 2026-03-31 | 6,100,175 | — | $0 | 6,100,175 | SEC↗ |
| Morris David K | See Remarks | M Exercise deriv | 2026-03-28 | 2026-03-31 | 641,869 | — | $0 | 641,870 | SEC↗ |
| Forbes Kendall | See Remarks | M Exercise deriv | 2026-03-28 | 2026-03-31 | 608,570 | — | $0 | 608,570 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner | M Exercise deriv | 2026-03-28 | 2026-03-31 | 6,100,175 | — | $0 | 6,100,175 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | M Exercise deriv | 2026-03-28 | 2026-03-31 | 471,057 | — | $0 | 471,057 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | M Exercise deriv | 2026-03-28 | 2026-03-31 | 6,100,175 | — | $0 | 6,100,175 | SEC↗ |
| Pharmacy Investors, LLC | Other | M Exercise deriv | 2026-03-28 | 2026-03-31 | 1,413,939 | — | $0 | 1,413,939 | SEC↗ |
| Burke Fred | See Remarks | M Exercise | 2026-03-28 | 2026-03-31 | 1,298,826 | — | $0 | 2,139,239 | SEC↗ |
| Ackerman John | Director | M Exercise | 2026-03-28 | 2026-03-31 | 471,057 | — | $0 | 816,180 | SEC↗ |
| Ackerman John | Director | M Exercise | 2026-03-28 | 2026-03-31 | 1,413,939 | — | $0 | 2,449,867 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner | M Exercise | 2026-03-28 | 2026-03-31 | 6,100,175 | — | $0 | 10,569,491 | SEC↗ |
| Morris David K | See Remarks | M Exercise | 2026-03-28 | 2026-03-31 | 641,869 | — | $0 | 896,341 | SEC↗ |
| Forbes Kendall | See Remarks | M Exercise | 2026-03-28 | 2026-03-31 | 608,570 | — | $0 | 1,061,826 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner | M Exercise | 2026-03-28 | 2026-03-31 | 6,100,175 | — | $0 | 10,569,491 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | M Exercise | 2026-03-28 | 2026-03-31 | 471,057 | — | $0 | 816,180 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | M Exercise | 2026-03-28 | 2026-03-31 | 6,100,175 | — | $0 | 10,569,491 | SEC↗ |
| Pharmacy Investors, LLC | Other | M Exercise | 2026-03-28 | 2026-03-31 | 1,413,939 | — | $0 | 2,449,867 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | S Sale | 2026-03-20 | 2026-03-24 | 275,728 | $29.68 | $8.18M | 345,123 | SEC↗ |
| Forbes Kendall | See Remarks | S Sale | 2026-03-20 | 2026-03-24 | 346,672 | $29.68 | $10.29M | 453,256 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | S Sale | 2026-03-20 | 2026-03-24 | 3,570,677 | $29.68 | $105.98M | 4,469,316 | SEC↗ |
| Ackerman John | Director | S Sale | 2026-03-20 | 2026-03-24 | 827,636 | $29.68 | $24.56M | 1,035,928 | SEC↗ |
| Ackerman John | Director | S Sale | 2026-03-20 | 2026-03-24 | 275,728 | $29.68 | $8.18M | 345,123 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner | S Sale | 2026-03-20 | 2026-03-24 | 3,570,677 | $29.68 | $105.98M | 4,469,316 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner | S Sale | 2026-03-20 | 2026-03-24 | 3,570,677 | $29.68 | $105.98M | 4,469,316 | SEC↗ |
| Morris David K | See Remarks | S Sale | 2026-03-20 | 2026-03-24 | 187,855 | $29.68 | $5.58M | 254,472 | SEC↗ |
| Burke Fred | See Remarks | S Sale | 2026-03-20 | 2026-03-24 | 671,432 | $29.68 | $19.93M | 840,413 | SEC↗ |
| Pharmacy Investors, LLC | Other | S Sale | 2026-03-20 | 2026-03-24 | 827,636 | $29.68 | $24.56M | 1,035,928 | SEC↗ |
| Forbes Kendall | See Remarks | A Award | 2026-03-01 | 2026-03-03 | 8,952 | — | $0 | 799,928 | SEC↗ |
| Morris David K | See Remarks | A Award | 2026-03-01 | 2026-03-03 | 8,952 | — | $0 | 442,327 | SEC↗ |
| Morris David K | See Remarks | A Award deriv | 2026-02-11 | 2026-02-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Burke Fred | See Remarks | A Award deriv | 2026-02-11 | 2026-02-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Forbes Kendall | See Remarks | A Award deriv | 2026-02-11 | 2026-02-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Forbes Kendall | See Remarks | G Gift | 2025-12-04 | 2025-12-08 | 21,500 | — | $0 | 790,976 | SEC↗ |
| Burke Fred | See Remarks | G Gift | 2025-12-04 | 2025-12-08 | 200,000 | — | $0 | 1,511,845 | SEC↗ |
| COSLER STEVEN D | Director | P Buy | 2025-12-03 | 2025-12-05 | 3,370 | $29.61 | $99.8K | 24,984 | SEC↗ |
| Burke Fred | See Remarks | M Exercise deriv | 2025-09-27 | 2025-09-30 | 1,298,826 | — | $0 | 2,597,651 | SEC↗ |
| Pharmacy Investors, LLC | Other | M Exercise deriv | 2025-09-27 | 2025-09-30 | 1,413,940 | — | $0 | 2,827,878 | SEC↗ |
| Morris David K | See Remarks | M Exercise deriv | 2025-09-27 | 2025-09-30 | 641,869 | — | $0 | 1,283,739 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | M Exercise deriv | 2025-09-27 | 2025-09-30 | 6,100,176 | — | $0 | 12,200,350 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner | M Exercise deriv | 2025-09-27 | 2025-09-30 | 6,100,176 | — | $0 | 12,200,350 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner | M Exercise deriv | 2025-09-27 | 2025-09-30 | 6,100,176 | — | $0 | 12,200,350 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | M Exercise deriv | 2025-09-27 | 2025-09-30 | 471,057 | — | $0 | 942,114 | SEC↗ |
| Forbes Kendall | See Remarks | M Exercise deriv | 2025-09-27 | 2025-09-30 | 608,570 | — | $0 | 1,217,140 | SEC↗ |
| Ackerman John | Director | M Exercise deriv | 2025-09-27 | 2025-09-30 | 1,413,940 | — | $0 | 2,827,878 | SEC↗ |
| Ackerman John | Director | M Exercise deriv | 2025-09-27 | 2025-09-30 | 471,057 | — | $0 | 942,114 | SEC↗ |
| Burke Fred | See Remarks | M Exercise | 2025-09-27 | 2025-09-30 | 1,298,826 | — | $0 | 1,711,845 | SEC↗ |
| Pharmacy Investors, LLC | Other | M Exercise | 2025-09-27 | 2025-09-30 | 1,413,940 | — | $0 | 1,863,564 | SEC↗ |
| Morris David K | See Remarks | M Exercise | 2025-09-27 | 2025-09-30 | 641,869 | — | $0 | 856,364 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | M Exercise | 2025-09-27 | 2025-09-30 | 6,100,176 | — | $0 | 8,039,993 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner | M Exercise | 2025-09-27 | 2025-09-30 | 6,100,176 | — | $0 | 8,039,993 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner | M Exercise | 2025-09-27 | 2025-09-30 | 6,100,176 | — | $0 | 8,039,993 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | M Exercise | 2025-09-27 | 2025-09-30 | 471,057 | — | $0 | 620,851 | SEC↗ |
| Forbes Kendall | See Remarks | M Exercise | 2025-09-27 | 2025-09-30 | 608,570 | — | $0 | 812,476 | SEC↗ |
| Ackerman John | Director | M Exercise | 2025-09-27 | 2025-09-30 | 471,057 | — | $0 | 620,851 | SEC↗ |
| Ackerman John | Director | M Exercise | 2025-09-27 | 2025-09-30 | 1,413,940 | — | $0 | 1,863,564 | SEC↗ |
| Pharmacy Investors, LLC | Other | S Sale | 2025-05-28 | 2025-09-30 | 150,998 | $20.16 | $3.04M | 449,624 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | S Sale | 2025-05-28 | 2025-09-30 | 50,305 | $20.16 | $1.01M | 149,794 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 651,454 | $20.16 | $13.13M | 1,939,817 | SEC↗ |
| Forbes Kendall | See Remarks | S Sale | 2025-05-28 | 2025-05-29 | 64,991 | $20.16 | $1.31M | 203,906 | SEC↗ |
| Burke Fred | See Remarks | S Sale | 2025-05-28 | 2025-05-29 | 138,705 | $20.16 | $2.80M | 413,019 | SEC↗ |
| Morris David K | See Remarks | S Sale | 2025-05-28 | 2025-05-29 | 68,547 | $20.16 | $1.38M | 214,495 | SEC↗ |
| Ackerman John | Director | S Sale | 2025-05-28 | 2025-05-29 | 50,305 | $20.16 | $1.01M | 149,794 | SEC↗ |
| Ackerman John | Director | S Sale | 2025-05-28 | 2025-05-29 | 150,998 | $20.16 | $3.04M | 449,624 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 651,454 | $20.16 | $13.13M | 1,939,817 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 651,454 | $20.16 | $13.13M | 1,939,817 | SEC↗ |
| Pharmacy Investors, LLC | Other | S Sale | 2025-05-27 | 2025-09-30 | 813,318 | $20.16 | $16.40M | 600,622 | SEC↗ |
| Cardinal Equity Fund, L.P. | Other | S Sale | 2025-05-27 | 2025-09-30 | 270,958 | $20.16 | $5.46M | 200,099 | SEC↗ |
| Bindley Capital Partners I, LL | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 3,508,905 | $20.16 | $70.74M | 2,591,271 | SEC↗ |
| Forbes Kendall | See Remarks | S Sale | 2025-05-27 | 2025-05-29 | 350,058 | $20.16 | $7.06M | 268,897 | SEC↗ |
| Burke Fred | See Remarks | S Sale | 2025-05-27 | 2025-05-29 | 747,102 | $20.16 | $15.06M | 551,724 | SEC↗ |
| Morris David K | See Remarks | S Sale | 2025-05-27 | 2025-05-29 | 369,212 | $20.16 | $7.44M | 283,042 | SEC↗ |
| Ackerman John | Director | S Sale | 2025-05-27 | 2025-05-29 | 813,318 | $20.16 | $16.40M | 600,622 | SEC↗ |
| Ackerman John | Director | S Sale | 2025-05-27 | 2025-05-29 | 270,958 | $20.16 | $5.46M | 200,099 | SEC↗ |
| Salentine Thomas J Jr | Director, 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 3,508,905 | $20.16 | $70.74M | 2,591,271 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 3,508,905 | $20.16 | $70.74M | 2,591,271 | SEC↗ |
| LEWIS RANDALL J | Director | A Award | 2025-05-09 | 2025-05-12 | 3,901 | — | $0 | 11,043 | SEC↗ |
| Patchett Mary Sue | Director | A Award | 2025-05-09 | 2025-05-12 | 3,901 | — | $0 | 11,043 | SEC↗ |
| COSLER STEVEN D | Director | A Award | 2025-05-09 | 2025-05-12 | 3,901 | — | $0 | 21,614 | SEC↗ |
| Burke Fred | See Remarks | M Exercise deriv | 2025-03-28 | 2025-04-01 | 1,298,826 | — | $0 | 3,896,477 | SEC↗ |
| Salentine Thomas J Jr | Director | M Exercise deriv | 2025-03-28 | 2025-04-01 | 6,100,176 | — | $0 | 18,300,526 | SEC↗ |
| Forbes Kendall | See Remarks | M Exercise deriv | 2025-03-28 | 2025-04-01 | 608,570 | — | $0 | 1,825,710 | SEC↗ |
| Ackerman John | Director | M Exercise deriv | 2025-03-28 | 2025-04-01 | 471,057 | — | $0 | 1,413,171 | SEC↗ |
| Ackerman John | Director | M Exercise deriv | 2025-03-28 | 2025-04-01 | 1,413,940 | — | $0 | 4,241,818 | SEC↗ |
| Morris David K | See Remarks | M Exercise deriv | 2025-03-28 | 2025-04-01 | 641,869 | — | $0 | 1,925,608 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | M Exercise deriv | 2025-03-28 | 2025-04-01 | 6,100,176 | — | $0 | 18,300,526 | SEC↗ |
| Burke Fred | See Remarks | M Exercise | 2025-03-28 | 2025-04-01 | 1,298,826 | — | $0 | 1,298,826 | SEC↗ |
| Salentine Thomas J Jr | Director | M Exercise | 2025-03-28 | 2025-04-01 | 6,100,176 | — | $0 | 6,100,176 | SEC↗ |
| Forbes Kendall | See Remarks | M Exercise | 2025-03-28 | 2025-04-01 | 608,570 | — | $0 | 618,955 | SEC↗ |
| Ackerman John | Director | M Exercise | 2025-03-28 | 2025-04-01 | 471,057 | — | $0 | 471,057 | SEC↗ |
| Ackerman John | Director | M Exercise | 2025-03-28 | 2025-04-01 | 1,413,940 | — | $0 | 1,413,940 | SEC↗ |
| Morris David K | See Remarks | M Exercise | 2025-03-28 | 2025-04-01 | 641,869 | — | $0 | 652,254 | SEC↗ |
| BINDLEY WILLIAM E | Director, 10% Owner | M Exercise | 2025-03-28 | 2025-04-01 | 6,100,176 | — | $0 | 6,100,176 | SEC↗ |
| Morris David K | See Remarks | A Award | 2025-02-05 | 2025-02-07 | 10,385 | — | $0 | 10,385 | SEC↗ |
| Forbes Kendall | See Remarks | A Award | 2025-02-05 | 2025-02-07 | 10,385 | — | $0 | 10,385 | SEC↗ |
| COSLER STEVEN D | Director | P Buy | 2024-11-19 | 2024-11-20 | 7,000 | $21.22 | $148.5K | 17,713 | SEC↗ |
| Forbes Kendall | See Remarks | A Award deriv | 2024-09-27 | 2024-10-01 | 2,434,280 | — | $0 | 2,434,280 | SEC↗ |
| Salentine Thomas J Jr | Director | A Award deriv | 2024-09-27 | 2024-10-01 | 24,400,702 | — | $0 | 24,400,702 | SEC↗ |
| Ackerman John | Director | A Award deriv | 2024-09-27 | 2024-10-01 | 5,655,758 | — | $0 | 5,655,758 | SEC↗ |
| Ackerman John | Director | A Award deriv | 2024-09-27 | 2024-10-01 | 1,884,228 | — | $0 | 1,884,228 | SEC↗ |
| Burke Fred | See Remarks | A Award deriv | 2024-09-27 | 2024-10-01 | 5,195,303 | — | $0 | 5,195,303 | SEC↗ |
| Morris David K | See Remarks | A Award deriv | 2024-09-27 | 2024-10-01 | 2,567,477 | — | $0 | 2,567,477 | SEC↗ |
| BINDLEY WILLIAM E | Director | A Award deriv | 2024-09-27 | 2024-10-01 | 24,400,702 | — | $0 | 24,400,702 | SEC↗ |
| COSLER STEVEN D | Director | A Award | 2024-09-27 | 2024-10-01 | 3,571 | — | $0 | 10,713 | SEC↗ |
| COSLER STEVEN D | Director | P Buy | 2024-09-27 | 2024-10-01 | 7,142 | $14.00 | $100.0K | 7,142 | SEC↗ |
| LEWIS RANDALL J | Director | A Award | 2024-09-27 | 2024-10-01 | 3,571 | — | $0 | 7,142 | SEC↗ |
| LEWIS RANDALL J | Director | P Buy | 2024-09-27 | 2024-10-01 | 3,571 | $14.00 | $50.0K | 3,571 | SEC↗ |
| Patchett Mary Sue | Director | P Buy | 2024-09-27 | 2024-10-01 | 3,571 | $14.00 | $50.0K | 3,571 | SEC↗ |
| Patchett Mary Sue | Director | A Award | 2024-09-27 | 2024-10-01 | 3,571 | — | $0 | 7,142 | SEC↗ |
| Salentine Thomas J Jr | Director | P Buy | 2024-09-27 | 2024-10-01 | 35,714 | $14.00 | $500.0K | 35,714 | SEC↗ |